James F Chang

US Patent:

6959015, Oct 25, 2005

Filed:

May 9, 2001

Appl. No.:

09/852819

Inventors:

Jin H. Hwang - Cerritos CA, US
James C. Chang - Cypress CA, US
Mark L. Yang - Irvine CA, US

Assignee:

Crest Microsystems - Cerritos CA

International Classification:

H04J003/06
H04L025/00
G06F001/12

US Classification:

370516, 370503, 370506, 375372, 713400

Abstract:

The invention provides a novel scheme to align data streams across multiple transmission channels and match multiple transmissions with one receiving rate. The channel aligning aspect of this invention detects the occurrence of an aligning character in a plurality of input channel character streams, buffers the character stream until an aligning character has been detected on every input channel. The channel aligning system transmits filler characters over every output channel corresponding to an input channel where an aligning character has been received if an aligning character has not been detected on every input channel. The aligning system then synchronously transmits the buffered characters, starting with the aligning character and proceeding with the subsequently received characters. The rate matching aspect of this invention receives a plurality of character streams synchronized by a first clock and buffers the character streams. Buffered characters are then transmitted over one or more output channels synchronized by a second clock.

US Patent:

6969706, Nov 29, 2005

Filed:

May 12, 2004

Appl. No.:

10/844647

Inventors:

Chin-Ming Chang - Tustin CA, US
James Chang - Newport Beach CA, US
Robert T. Lyons - Laguna Hills CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K031/724

US Classification:

514 60, 514912, 514914, 514970, 536103

Abstract:

A composition comprising a cyclodextrin, a guanidine-based cationic compound, and sorbic acid is disclosed herein. Preservatives and methods related thereto, and experimental results suggesting certain advantages related to these compositions, preservatives, and methods are also presented herein.

US Patent:

7501393, Mar 10, 2009

Filed:

Jul 27, 2005

Appl. No.:

11/161218

Inventors:

Walter L. Tien - Irvine CA, US
Richard Graham - Irvine CA, US
James N. Chang - Newport Beach CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 38/12

US Classification:

514 11, 530317, 424 1032, 554168

Abstract:

A composition is described herein comprising cyclosporin A, polysorbate 80, a polyoxyethylene stearate, and an oil; wherein the composition is an emulsion which is ophthalmically acceptable. Methods of treating diseases or conditions using said compositions, and medicaments related thereto, are also disclosed herein.

US Patent:

7851504, Dec 14, 2010

Filed:

Mar 16, 2005

Appl. No.:

11/083261

Inventors:

Chin-Ming Chang - Tustin CA, US
James N. Chang - Newport Beach CA, US
Rhett M. Schiffman - Laguna Beach CA, US
R. Scott Jordan - Trabuco Canyon CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 31/19
A61K 31/215

US Classification:

514530, 514573

Abstract:

A composition comprising from 0. 005% to 0. 02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.

US Patent:

8278353, Oct 2, 2012

Filed:

Feb 10, 2012

Appl. No.:

13/370574

Inventors:

Chin-Ming Chang - Tustin CA, US
James N. Chang - Newport Beach CA, US
Rhett M. Schiffman - Laguna Beach CA, US
R. Scott Jordan - Trabuco Canyon CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 31/19
A61K 31/215

US Classification:

514530, 514573

Abstract:

A composition comprising from 0. 005% to 0. 02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein.

US Patent:

8299118, Oct 30, 2012

Filed:

Feb 10, 2012

Appl. No.:

13/370529

Inventors:

Chin-Ming Chang - Tustin CA, US
James N. Chang - Newport Beach CA, US
Rhett M. Schiffman - Laguna Beach CA, US
R. Scott Jordan - Trabuco Canyon CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 31/19
A61K 31/215

US Classification:

514530, 514573

Abstract:

A composition comprising from 0. 005% to 0. 02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.

US Patent:

8309605, Nov 13, 2012

Filed:

Dec 10, 2010

Appl. No.:

12/965514

Inventors:

Chin-Ming Chang - Tustin CA, US
James N. Chang - Newport Beach CA, US
Rhett M. Schiffman - Laguna Beach CA, US
R. Scott Jordan - Trabuco Canyon CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 31/19
A61K 31/215

US Classification:

514530, 514573

Abstract:

A composition comprising from 0. 005% to 0. 02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.

US Patent:

8338479, Dec 25, 2012

Filed:

Jan 9, 2009

Appl. No.:

12/351383

Inventors:

Chin-Ming Chang - Tustin CA, US
James N. Chang - Newport Beach CA, US
Rhett M. Schiffman - Laguna Beach CA, US
R. Scott Jordan - Trabuco Canyon CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 31/19
A61K 31/215

US Classification:

514530, 514573

Abstract:

A composition comprising from 0. 005% to 0. 02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.

Address:

9813 Bridleridge Ct, Vienna, VA 22181

VIN:

4S4BP61C177318688

Make:

SUBARU

Model:

OUTBACK

Year:

2007